Popular Trials
Procedure
Live Donor Liver Transplantation for Colorectal Cancer Liver Metastases
Recruiting1 award
Toronto, Ontario
This trial will offer live donor liver transplantation to select patients with unresectable metastases that are 1) limited to the liver and 2) stable (non-progressing) on standard chemotherapy.
Behavioral Intervention
LIFT + REAP for Frailty in Liver Transplant Candidates
Recruiting1 award4 criteria
Chicago, Illinois
This trial will test a new intervention to improve frailty in patients awaiting liver transplant. The intervention includes an evaluation by a physical therapist, an individualized home exercise prescription, and exercise tracking using a smart phone application. The investigators also aim to perform "Realistic Effort Action Planning" in a subset of patients to determine if this enhances the intervention.
Procedure
Liver Transplant for Bile Duct Cancer
Recruiting1 award9 criteria
Toronto, Ontario
This trial is for patients with intrahepatic cholangiocarcinoma who have achieved 6 months of disease stability while receiving standard chemotherapy. If eligible, they will be listed for transplantation. After transplantation, they will be followed for disease recurrence and overall survival.
Popular Filters
Trials for Hepatocellular Carcinoma Patients
Checkpoint Inhibitor
Radiotherapy + Immunotherapy for Liver Cancer
Recruiting1 awardPhase 1 & 2
Toronto, Ontario
This trial aims to see if combining a type of local therapy and immunotherapy can help patients with liver cancer and blood vessel invasion become eligible for liver transplantation. The trial will assess how many patients can get
Monoclonal Antibodies
Atezolizumab + Bevacizumab for Liver Cancer
Recruiting3 awardsPhase 4
Houston, Texas
This trial will test whether a combination of two drugs can help treat liver cancer in patients who are eligible for transplantation. The drugs will be given for six months before the transplant procedure.
Trials for Liver Cancer Patients
Checkpoint Inhibitor
Radiotherapy + Immunotherapy for Liver Cancer
Recruiting1 awardPhase 1 & 2
Toronto, Ontario
This trial aims to see if combining a type of local therapy and immunotherapy can help patients with liver cancer and blood vessel invasion become eligible for liver transplantation. The trial will assess how many patients can get
Monoclonal Antibodies
Atezolizumab + Bevacizumab for Liver Cancer
Recruiting3 awardsPhase 4
Houston, Texas
This trial will test whether a combination of two drugs can help treat liver cancer in patients who are eligible for transplantation. The drugs will be given for six months before the transplant procedure.
Trials With No Placebo
Checkpoint Inhibitor
Radiotherapy + Immunotherapy for Liver Cancer
Recruiting1 awardPhase 1 & 2
Toronto, Ontario
This trial aims to see if combining a type of local therapy and immunotherapy can help patients with liver cancer and blood vessel invasion become eligible for liver transplantation. The trial will assess how many patients can get
Immunosuppressant
Prograf vs Envarsus for Liver Transplant Patients
Recruiting3 awardsPhase 4
Toronto, Ontario
"This trial compares two different forms of a medication called Tacrolimus used to prevent organ rejection in liver transplant patients. The study will look at how Prograf and Envarsus affect liver and kidney function
Behavioral Intervention
mHealth Messaging for Transplant Medication Adherence
Recruiting1 award
Baltimore, Maryland
"This trial aims to see if a mobile technology intervention can help young people who have had kidney or liver transplants to remember to take their medication on time. The intervention includes an electronic pillbox and text
Procedure
TIPS Procedure for Liver Cirrhosis and Muscle Loss
Recruiting1 awardPhase < 1
Portland, Oregon
This trial will test whether TIPS creation leads to improved muscle mass, body composition and muscle function within the first 12 months after the procedure compared to a control group without TIPS, and whether these changes improve liver disease outcomes in patients awaiting liver transplantation.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.